Nanowired drug delivery of antioxidant compound H-290/51 enhances neuroprotection in hyperthermia-induced neurotoxicity

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 1, 2012, Pages 50-64

  Muresanu, Dafin F ^a   Sharma, Aruna ^b   Tian, Z Ryan ^c   Smith, Mark A ^d   Sharma, Hari Shanker ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF ARKANSAS   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; blood brain barrier; Brain edema; Brain pathology; H 290 51; Heat stress; Hyperthermia; Nano drug delivery; Nanoparticles; Nanowiring

Indexed keywords

ANTIOXIDANT; CARBON NANOTUBE; COMPOUND H 290; COMPOUND H 51; GLIAL FIBRILLARY ACIDIC PROTEIN; MORPHINE; NANOWIRE; QUANTUM DOT; RADIOACTIVE IODINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; DRUG DELIVERY SYSTEM; GLIA CELL; HEART STRESS; HYPERTHERMIA; IMMUNOHISTOCHEMISTRY; MOTOR DYSFUNCTION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REVIEW; TEMPERATURE STRESS; THERMAL EXPOSURE;

EID: 84860347901     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712799960736     Document Type: Review

References (84)

1. Sharma, H.S.; Sharma, A. Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2012, 4(2), 184-203.
2. Sharma, H.S. Early microvascular reactions and blood-spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection. J. Neural Transm., 2011, 118(1), 155-176.
3. Sharma, H.S.; Ali, S.F.; Tian, Z.R.; Patnaik, R.; Patnaik, S.; Sharma, A.; Boman, A.; Lek, P.; Seifert, E.; Lundstedt, T. Nanowired-drug delivery enhances neuroprotective efficacy of compounds and reduces spinal cord edema formation and improves functional outcome following spinal cord injury in the rat. Acta Neurochir. Suppl., 2010, 106, 343-350.
4. Uskoković, V.; Lee, P.P.; Walsh, L.A.; Fischer, K.E.; Desai, T.A. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. Biomaterials, 2012, 33(5), 1663-1672.
5. Julien, D.C.; Richardson, C.C.; Beaux, M.F., 2nd; McIlroy, D.N.; Hill, R.A. In vitro proliferating cell models to study cytotoxicity of silica nanowires. Nanomedicine, 2010, 6(1), 84-92.
6. Kwon, N.H.; Beaux, M.F., 2nd; Ebert, C.; Wang, L.; Lassiter, B.E.; Park, Y.H.; McIlroy, D.N.; Hovde, C.J.; Bohach, G.A. Nanowire-based delivery of Escherichia coli O157 shiga toxin 1 A subunit into human and bovine cells. NanoLetters, 2007, 7(9), 2718-2723.
7. Zhao, L.; Hu, L.; Huo, K.; Zhang, Y.; Wu, Z.; Chu, P.K. Mechanism of cell repellence on quasi-aligned nanowire arrays on Ti alloy. Biomaterials, 2010, 31(32), 8341-8349.
8. Sharma, H.S.; Muresanu, D.F.; Sharma, A.; Patnaik, R.; Lafuente, J.V. Nanoparticles influence pathophysiology of spinal cord injury and repair. Prog. Brain Res., 2009, 180, 154-180.
9. Sharma, H.S.; Muresanu, D.F.; Patnaik, R.; Stan, A.D.; Vacaras, V.; Perju-Dumbrav, L.; Alexandru, B.; Buzoianu, A.; Opincariu, I.; Menon, P.K.; Sharma, A. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat. J. Nanosci. Nanotechnol., 2011, 11(9), 7549-7569.
10. Sharma, H.S.; Patnaik, R.; Sharma, A. Diabetes aggravates nanoparticles induced breakdown of the blood-brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J. Nanosci. Nanotechnol., 2010, 10(12), 7931-7945.
11. Sharma, H.S.; Ali, S.F.; Tian, Z.R.; Hussain, S.M.; Schlager, J.J.; Sjöquist, P.O.; Sharma, A.; Muresanu, D.F. Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. J. Nanosci. Nanotechnol., 2009, 9(8), 5073-5090.
12. Sharma, H.S.; Patnaik, R.; Sharma, A.; Sjöquist, P.O.; Lafuente, J.V. Silicon dioxide nanoparticles (SiO2, 40-50 nm) exacerbate pathophysiology of traumatic spinal cord injury and deteriorate functional outcome in the rat. An experimental study using pharmacological and morphological approaches. J. Nanosci. Nanotechnol., 2009, 9(8), 4970-4980.
13. Fischer, K.E.; Nagaraj, G.; Hugh Daniels, R.; Li, E.; Cowles, V.E.; Miller, J.L.; Bunger, M.D.; Desai, T.A. Hierarchical nanoengineered surfaces for enhanced cytoadhesion and drug delivery. Biomaterials, 2011, 32(13), 3499-3506.
14. Porter, J.R.; Henson, A.; Ryan, S.; Popat, K.C. Biocompatibility and mesenchymal stem cell response to poly(epsilon-caprolactone) nanowire surfaces for orthopedic tissue engineering. Tissue Eng. Part A, 2009, 15(9), 2547-2559.
15. Pearton, S.J.; Lele, T.; Tseng, Y.; Ren, F. Penetrating living cells using semiconductor nanowires. Trends Biotechnol., 2007, 25(11), 481-482.
16. Lv, M.; Su, S.; He, Y.; Huang, Q.; Hu, W.; Li, D.; Fan, C.; Lee, S.T. Long-term antimicrobial effect of silicon nanowires decorated with silver nanoparticles. Adv. Mater., 2010, 22(48), 5463-5467.
17. Zhao, H.; Dong, W.; Zheng, Y.; Liu, A.; Yao, J.; Li, C.; Tang, W.; Chen, B.; Wang, G.; Shi, Z. The structural and biological properties of hydroxyapatite-modified titanate nanowire scaffolds. Biomaterials, 2011, 32(25), 5837-5846.
18. Cho, Y.; Borgens, R.B. Polymer and nano-technology applications for repair and reconstruction of the central nervous system. Exp. Neurol., 2011, [Epub ahead of print].
19. Sharma, H.S. Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery. J. Neural Transm., 2011, 118(1), 3-6.
20. Fernandes, C.; Soni, U.; Patravale, V. Nano-interventions for neurodegenerative disorders. Pharmacol. Res., 2010, 62(2), 166-178.
21. Campbell, A.; Oldham, M.; Becaria, A.; Bondy, S.C.; Meacher, D.; Sioutas, C.; Misra, C.; Mendez, L.B.; Kleinman, M. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology, 2005, 26, 133-140.
22. Bennett, W.D. Rapid translocation of nanoparticles from the lung to the bloodstream? Am. J. Respir. Crit. Care Med., 2002, 165(12), 1671-1672.
23. Brooking, J.; Davis, S.S.; Illum, L. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target, 2001, 9(4), 267-279.
24. Florence, A.T.; Hillery, A.M.; Hussain, N.; Jani, P.U. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J. Drug Target, 1995, 3(1), 65-70.
25. Gao, K.; Jiang, X. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int. J. Pharm., 2006, 310(1-2), 213-219.
26. Sharma, H.S.; Sharma, A.; Hussain, S.; Schlager, J.; Sjöquist, P.O.; Muresanu, D. A new antioxidant compound H-290/51 attenuates nanoparticle induced neurotoxicity and enhances neurorepair in hyperthermia. Acta Neurochir. Suppl., 2010, 106, 351-357.
27. Bodian, D.; Howe, H.A. Experimental studies on intraneural spread of poliomyelitis virus. Bull. Johns Hopkins Hosp., 1941a, 69, 248-267.
28. Bodian, D.; Howe, H.A. The rate of progression of poliomyelitis virus in nerves. Bull. Johns Hopkins Hosp., 1941b, 69, 79-85.
29. Howe, H.A.; Bodian, D. Portals of entry of poliomyelitis virus in the chimpanzee. Proc. Soc. Exp. Biol. Med., 1940, 43, 718-721.
30. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect., 2005, 113(7), 823-839.
31. Elder, A.; Gelein, R.; Silva, V.; Feikert, T.; Opanashuk, L.; Carter, J.; Potter, R.; Maynard, A.; Ito, Y.; Finkelstein, J.; Oberdorster, G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect., 2006, 114(8), 1172-1178.
32. Tiwari, S.B.; Amiji, M.M. A review of nanocarrier-based CNS delivery systems. Curr. Drug Deliv., 2006, 3(2), 219-232.
33. Sharma, H.S.; Sharma, A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog. Brain Res., 2007, 162, 245-273.
34. Brown, D.M.; Stone, V.; Findlay, P.; MacNee, W.; Donaldson, K. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup. Environ. Med., 2000, 57, 685-691.
35. Brown, D.M.; Wilson, M.R.; MacNee, W.; Stone, V.; Donaldson, K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol., 2001, 175, 191-199.
36. Derfus, A.M.; Chan, W.C.W.; Bhatia, S.N. Probing the cytotoxicity of semiconductor quantum dots. NanoLetters, 2004, 4(1), 11-18.
37. Joo, S.H.; Feitz, A.J.; Waite, T.D. Oxidative degradation of the carbothioate herbicide, molinate, using nanoscale zerovalent iron. Environ. Sci. Technol., 2004, 38, 2242-2247.
38. Li, N.; Sioutas, C.; Cho, A.; Schmitz, D.; Misra, C.; Sempf, J.; Wang, M.; Oberley, T.; Froines, J.; Nel, A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ. Health Perspect., 2003, 111, 455-460.
39. Oberdörster, E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in brain of juvenile largemouth bass. Environ. Health Perspect., 2004a, 112, 1058-1062.
40. Sayes, C.; Fortner, J.; Guo, W.; Lyon, D.; Boyd, A.M.; Ausman, K.D.; Tao, Y.J.; Sitharaman, B.; Wilson, L.J.; Hughes, J.B.; West, J.L.; Colvin, V.L. The differential cytotoxicity of water-soluble fullerenes. NanoLetters, 2004, 4, 1881-1887.
41. Shvedova, A.A.; Kisin, E.R.; Murray, A.; Kommineni, C.; Vallyathan, V.; Castranova, V. Pro/antioxidant status in murine skin following topical exposure to cumene hydroperoxide throughout the ontogeny of skin cancer. Biochemistry (Mosc.), 2004, 69(1), 23-31.
42. Shvedova, A.A.; Kisin, E.R.; Mercer, R.; Murray, A.R.; Johnson, V.J.; Potapovich, A.I.; Tyurina, Y.Y.; Gorelik, O.; Arepalli, S.; Schwegler-Berry, D.; Hubbs, A.F.; Antonini, J.; Evans, D.E.; Ku, B.K.; Ramsey, D.; Maynard, A.; Kagan, V.E.; Castranova, V.; Baron, P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell Mol. Physiol., 2005, 289(5), L698-L708.
43. Sharma, H.S. Methods to induce Bran Hyperthermia, In: Current Protocols in Toxicology (Solicited Contribution); 2005b, Suppl 23, Unit 11.14:1-26.
44. Sharma, H.S.; Dey, P.K. Probable involvement of 5-hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats. Neuropharmacology, 1986, 25(2), 161-167.
45. Sharma, H.S.; Sjöquist, P.O. A new antioxidant compound H-290/51 modulates glutamate and GABA immunoreactivity in the rat spinal cord following trauma. Amino Acids, 2002, 23(1-3), 261-272.
46. Sharma, H.S.; Ali, S.F.; Dong, W.; Tian, Z.R.; Patnaik, R.; Patnaik, S.; Sharma, A.; Boman, A.; Lek, P.; Seifert, E.; Lundstedt, T. Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord. Ann. NY Acad. Sci., 2007, 1122, 197-218.
47. Sharma, H.S.; Ali, S.F.; Tian, Z.R.; Patnaik, R.; Patnaik, S.; Lek, P.; Sharma, A.; Lundstedt, T. Nano-drug delivery and neuroprotection in spinal cord injury. J. Nanosci. Nanotech., (in press).
48. Sharma, H.S. Hyperthermia influences excitatory and inhibitory amino acid neurotransmitters in the central nervous system. An experimental study in the rat using behavioural, biochemical, pharmacological, and morphological approaches. J. Neural Transm., 2006, 113(4), 497-519.
49. Sharma, H.S. Methods to produce hyperthermia-induced brain dysfunction. Prog. Brain Res., 2007, 162, 173-199.
50. Sharma, H.S.; Dey, P.K. Influence of long-term acute heat exposure on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. Brain Res., 1987, 424(1), 153-162.
51. Sharma, H.S. Pathophysiology of blood-brain barrier, brain edema and cell injury following hyperthermia: New role of heat shock protein, nitric oxide and carbon monoxide: an experimental study in the rat using light and electron microscopy. Acta Univ. Upsaliensis, 1999, 830, 1-94.
52. Sharma, H.S. Effect of captopril (a converting enzyme inhibitor) on blood-brain barrier permeability and cerebral blood flow in normotensive rats. Neuropharmacology, 1987, 26(1), 85-92.
53. Sharma, H.S.; Cervós-Navarro, J. Brain oedema and cellular changes induced by acute heat stress in young rats. Acta Neurochir. Suppl. (Wien.), 1990, 51, 383-386.
54. Elliott, K.A.C.; Jasper, H. Measurement of experimentally induced brain swelling and shrinkage. Am. J. Physiol., 1949, 157, 122-129.
55. Sharma, H.S.; Westman, J.; Nyberg, F. Pathophysiology of brain edema and cell changes following hyperthermic brain injury. Prog. Brain Res., 1998, 115, 351-412.
56. Sharma, H.S.; Zimmer, C.; Westman, J.; Cervós-Navarro, J. Acute systemic heat stress increases glial fibrillary acidic protein immunoreactivity in brain: experimental observations in conscious normotensive young rats. Neuroscience, 1992, 48(4), 889-901.
57. Sharma, H.S.; Kiyatkin, E.A. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J. Chem. Neuroanat., 2009, 37(1), 18-32.
58. Namdeo, A.; Bell, M.C. Characteristics and health implications of fine and coarse particulates at roadside, urban background and rural sites in UK. Environ. Int., 2005, 31, 565-573.
59. Chang, C.C.; Tsai, S.S.; Ho, S.C.; Yang, C.Y. Air pollution and hospital admissions for cardiovascular disease in Taipei, Taiwan. Environ. Res., 2005, 98, 114-119.
60. BéruBé, K.A.; Jones, T.P.; Moreno, T.; Sexton, K.; Balharry, D.; Hicks, M.; Merolla, L.; Mossman, B.T. Characterisation of airborne particulate matter and related mechanisms of toxicity. In: Ayres, J.; Maynard, R.; Richards, R., Eds.; Air Pollution Reviews, Vol 3. London: Imperial College Press, 2006, 3, 69-109.
61. Evans, S.A.; Al-Mosawi, A.; Adams, R.A.; Berube, K.A. Inflammation, edema, and peripheral blood changes in lung-compromised rats after instillation with combustion-derived and manufactured nanoparticles. Exp. Lung Res., 2006, 32(8), 363-378.
62. Osier, M.; Oberdörster, G. Intratracheal inhalation versus intratracheal instillation: differences in particulate effects. Fund. Appl. Toxicol., 1997, 40, 220-227.
63. Gianutsos, G.; Morrow, G.R.; Morris, J.B. Accumulation of manganese in rat brain following intranasal administration. Fundam. Appl. Toxicol., 1997, 37, 102-105.
64. Kennedy, P.; Chaudhuri, A. Herpes simplex encephalitis. J. Neurol. Neurosurg. Psychiatry, 2002, 73, 237-238.
65. Terasaki, S.; Kameyama, T.; Yamamoto, S. A case of zoster in the 2nd and 3rd branches of the trigeminal nerve associated with simultaneous herpes labialis infection-a case report. Kurume Med. J., 1997, 44(1), 61-66.
66. Hunter, D.D.; Undem, B.J. Identification and substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea. Am. J. Respir. Crit. Care Med., 1999, 159, 1943-1948.
67. Utell, M.; Frampton, M.; Zareba, W.; Devlin, R.; Cascio, W. Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal. Toxicol., 2002, 14, 1231-1247.
68. Inoue, K.; Takano, H.; Yanagisawa, R.; Hirano, S.; Sakurai, M.; Shimada, A.; Yoshikawa, T. Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice. Environ. Health Perspect., 2006, 114(9), 1325-1330.
69. Veronesi, B.; Makwana, O.; Pooler, M.; Chen, L.C. Effects of subchronic exposures to concentrated ambient particles. VII. Degeneration of dopaminergic neurons in Apo E-/-mice. Inhal. Toxicol., 2005, 17(4-5), 235-241.
70. Calderon-Garcidueñas, L.; Azzarelli, B.; Acuna, H.; Garcia, R.; Gambling, T.M.; Osnaya, N.; Monroy, S.; DEL Tizapantzi, M.R.; Carson, J.L.; Villarreal-Calderon, A.; Rewcastle, B. Air pollution and brain damage. Toxicol. Pathol., 2002, 30(3), 373-389.
71. de Lorenzo, A.J. The Olfactory Neuron and the Blood-Brain Barrier. In: Taste and Smell in Vertebrates; Wolstenholme, G.; Knight, J., Eds.; London, Churchill, 1970, pp. 151-176.
72. Foley, S.; Crowley, C.; Smaihi, M.; Bonfils, C.; Erlanger, B.F.; Seta, P.; Larroque, C. Cellular localisation of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun., 2002, 294, 116-119.
73. Gopinath, P.G.; Gopinath, G.; Kumar, A. Target site of intranasally sprayed substances and their transport across the nasal mucosa: a new insight into the intranasal route of drug delivery. Curr. Ther. Res., 1978, 23(5), 596-607.
74. Liu, G.; Men, P.; Harris, P.L.; Rolston, R.K.; Perry, G.; Smith, M.A. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neurosci. Lett., 2006, 406(3), 189-193.
75. Rodoslav, S.; Laibin, L.; Eisenberg, A.; Dusica, M. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science, 2003, 300, 615-618.
76. Kane, R.S.; Stroock, A.D. Nanobiotechnology: protein-nanomaterial interactions. Biotechnol. Prog., 2007, 23(2), 316-319.
77. Ijima, S. Helical microtubules of graphite carbon. Nature, 1991, 354, 56-58.
78. Wei, M.; Qi, Z.M.; Ichihara, M.; Honma, I.; Zhou, H. Synthesis of onedimensional sodium titanate nanostructures. J. Nanosci. Nanotechnol., 2007, 7(3), 1065-1068.
79. Dong, W.; Zhang, T.; McDonald, M.; Padilla, C.; Epstein, J.; Tian, Z.R. Biocompatible nanofiber scaffolds on metal for controlled release and cell colonization. Nanomedicine, 2006, 2(4), 248-252.
80. Chi, B.; Victorio, E.S.; Jin, T. Synthesis of TiO2-based nanotube on Ti substrate by hydrothermal treatment. J. Nanosci. Nanotechnol., 2007, 7(2), 668-672.
81. Silva, G.A.; Czeisler, C.; Niece, K.L.; Beniash, E.; Harrington, D.A.; Kessler, J.A.; Stupp, S.I. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science, 2004, 303(5662), 1352-1355.
82. Brokx, R.D.; Bisland, S.K.; Gariepy, J. Designing peptide-based scaffolds as drug delivery vehicles. J. Control Release, 2002, 78(1-3), 115-123.
83. Betbeder, D.; Sperandio, S.; Latapie, J.P.; de Nadai, J.; Etienne, A.; Zajac, J.M.; Frances, B. Biovector nanoparticles improve antinociceptive efficacy of nasal morphine. Pharm Res., 2000, 17(6), 743-748.
84. Brigger, I.; Morizet, J.; Aubert, G.; Chacun, H.; Terrier-Lacombe, M.J.; Couvreur, P.; Vassal, G. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J. Pharmacol. Exp. Ther., 2002, 303(3), 928-936.